Sign up to our newsletter
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis
LATEST ALERTS
View all Cannabis and cannabinoids in Europe
New trial available: Click on any alert below and access our regulatory alerts and get timely notifications sent to your inbox for 7 days.
Daily news alerts
Daily regulatory updates of legal changes in the cannabis sector, including monthly compilations
30th November 2023
Germany: A recent amendment to the Cannabis Act proposed by the coalition parties and the Ministry of Health has been leaked to the press. In addition to the changes previously reported by CannIntelligence, German producers of medical cannabis would no longer be limited to the tendering process and maximum quantities, and would be able to cultivate varieties according to market demand; regulations on private cultivation and possession would come into force on 1st April 2024, while regulations on associations would come into force on 1st July 2024. The second and final reading of the bill in the Bundestag (lower house) is scheduled for the first week of December.28th November 2023
- Germany: A product alert has been issued through the EU Safety Gate system for a nicotine-free e-cigarette cartridge containing cannabidiol, hexahydrocannabinol (HHC) and, in some cases, other cannabinoids – such as hexahydrocannabinol acetate (HHC-O) and hexahydrocannabiphorol (HHC-P). According to the warning, the product contains cannabidiol and cannabidiol derivatives that may be psychotoxic, it does not have a child-resistant fastener and is not tamper-proof, which poses a health risk in the hands of children and, therefore, does not comply with the Tobacco Products Directive. An immediate ban on sales has been imposed.
27th November 2023
- Germany: The Bundestag has agreed on amendments to the Cannabis Bill – which aims to regulate the self-cultivation of cannabis by adults and the non-commercial cultivation of cannabis by cannabis clubs – according to the press and an instagram post from Bundestag member Kirsten Kappert-Gonther. The measures include reducing the ban zone for public consumption around youth facilities from 200 m to 100 m, increasing the possession of home-grown cannabis to 50 g, and removing criminal liability for possession of between 25 g and 30 g in public and 50 g and 60 g in private. The second and final reading of the bill in the Bundestag is scheduled for the first week of December.
27th November 2023
- Malta: While commenting on the news that the government is considering stopping smoking for future generations, a group of non-governmental organisations (NGOs) and associations have reportedly called on the government to enact additional measures, such as stopping self-cultivation of cannabis, so children who live with parents who cultivate cannabis are protected.
24th November 2023
- EU: On Wednesday (22nd November), the European Parliament adopted its position on the proposal to revise the Packaging and Packaging Waste Directive. The directive aims to prevent the generation of packaging waste, reduce it in quantity, ensure that all packaging is recyclable, and increase the use of recycled plastics in packaging. Once the Council has adopted its position, the Parliament is ready to start talks with national governments on the law’s final form.
23rd November 2023
- Ukraine: Batkivshchyna, the small opposition party that opposes medical cannabis legalisation, has submitted dozens of amendments to bill 7457 that would legalise medical cannabis in the second reading, media reports. As reported, the party wants most of these amendments to be considered by the parliament session hall, which would drag out time and may prevent the law from passing.
22nd November 2023
- France: A joint committee made up of assembly members and senators has failed to agree on a common version of the 2024 Social Security Financing Bill after the Senate amended the text adopted by the National Assembly. The provisions to introduce a regulatory framework for cannabis-based medicines were only slightly amended. The bill returns to the National Assembly for a new reading.
16th November 2023
- EU: On occasion of today’s webinar held by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) examining the EU cannabis market, the authority has launched an interactive module describing the illicit European cannabis market, from production and trafficking, to distribution and use. Today’s webinar consisted of a presentation of this module, which goes through figures on the estimated annual value of this market in the EU, cannabis cultivation, quantities seized in the last ten years, implications for organised crime, available cannabis retail channels, pricing, and the environmental consequences of cannabis production.
15th November 2023
- EU: The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) – the European authority on illicit drugs – will hold a webinar tomorrow examining the EU cannabis market. Its speakers, in addition to delving into the environmental impact of cannabis production and new emerging products, will define key issues and will provide recommendations for action at EU and member state level.
14th November 2023
- Germany: The Federal Joint Committee (G-BA) – the highest decision-making body in the German statutory healthcare system – has opened the public consultation for the amendments to the medical products guidelines, in particular an amendment to the approval requirements for medical cannabis for patients covered by statutory health insurance. Among other things, the amendments include a two-week deadline for a decision on an application for product authorisation and the addition of an annex regulating the minimum requirements for medical qualification for the prescription of products. Comments can be submitted until 11th December 2023.
14th November 2023
- Slovenia: Amendments to the regulation on the classification of illicit drugs were published in the official gazette on the 10th November 2023. These include adding hexahydrocannabinol (HHC), its acetate (HHC-O), hexahydrocannabiphorol (HHCP) and tetrahydrocannabiphorol (THCP) to the narcotics list, making them subject to the narcotics regime. The amendments will enter into force 15 days after publication.
Market reports
Full-length in-depth reports with detailed data and analysis for individual markets around the world
Regulatory reports
Comprehensive legal reports outlining how the sector is regulated, interpretation of the laws and relevant bodies
Market data
Up-to-date information and insights on brands, pricing and retail across selected markets
Regulatory databases
Regularly updated global regulations currently in place, compiled into easy-to-read maps and tables
